LG Life Sciences Ltd.
Records under this name other than patents LG Life Sciences Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,879,848 | Dipeptidyl Peptidase-IV Inhibiting Compounds, Method of Preparing the Same, and Pharmaceutical Compositions Containing the Same as an Active Agent Formerly held In force · High confidence | In force | High confidence | |
| US 8,569,307 | Indole Compounds as an Inhibitor of Cellular Necrosis Formerly held In force · High confidence | In force | High confidence | |
| US 8,889,691 | Indole Compounds as an Inhibitor of Cellular Necrosis Formerly held In force · High confidence | In force | High confidence | |
| US 9,000,028 | Indole and Indazole Compounds as an Inhibitor of Cellular Necrosis Formerly held In force · High confidence | In force | High confidence | |
| US 8,222,414 | Indole Compounds as an Inhibitor of Cellular Necrosis Formerly held In force · High confidence | In force | High confidence | |
| US 8,309,586 | Glucokinase Activators and Pharmaceutical Compositions Containing the Same as an Active Ingredient Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,349,885 | Indole and Indazole Derivatives Having a Cell-, Tissue- and Organ-Preserving Effect Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,044,080 | Isoxazoline Derivative and Novel Process for Its Preparation Formerly held In force · High confidence | In force | High confidence | |
| US 8,436,038 | Indole and Indazole Compounds as an Inhibitor of Cellular Necrosis Formerly held In force · High confidence | In force | High confidence | |
| US 8,039,622 | Melanocortin Receptor Agonists Formerly held In force · High confidence | In force | High confidence |